[Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].


Multimodal therapy including neoadjuvant chemotherapy with subsequent extrapleural pneumonectomy and postoperative radiotherapy has been shown to improve the survival of patients with malignant pleural mesothelioma (MPM) if they are selected carefully. Careful patient selection is required in order to administer aggressive multimodal therapy only to… (More)
DOI: 10.1055/s-2008-1076790


  • Presentations referencing similar topics